Until now, gathering intelligence from medical congresses has relied heavily on manual note-taking and delayed reporting, often resulting in lost insights. Virtual Science AI’s new tool offers real-time intelligence on key trends and topics emerging from interactions at these events, connecting those insights with existing company data.
The launch builds on the success of Virtual Science AI’s existing Medical Intelligence Platform, already used by leading pharmaceutical and biotechnology firms. The company stated that Medical Congress AI has already been successfully deployed at major industry events, receiving positive feedback.
“Medical congresses are a critical setting for life science teams to connect with physicians and the patient community to advance scientific innovation to improve patients’ lives,” said Tom Hughes, CEO of Virtual Science AI. “However, groundbreaking insights from events often get lost and don’t reach the people who could utilize that information. Virtual Science AI’s Medical Congress AI solution solves for this.”
The platform allows teams to compliantly capture insights during and immediately after scientific exchange interviews and interactions. This represents a significant shift in how AI can support medical affairs teams with speed, accuracy, and trust, according to the company.
Geraldine Reilly, Head of Client Services at Virtual Science AI, highlighted the challenges of traditional methods. “I’ve been in the life science industry for over 20 years and have experienced the difficulty of remembering all the insightful conversations with key opinion leaders at the end of a busy conference,” she said. “Often, you focus on what’s significant for the company and miss critical information that’s valuable to clients. Our congress intelligence solution is truly a game-changer – capturing key takeaways during the event and delivering real-time information during and after.”
The development of Medical Congress AI reflects a broader trend of AI adoption within the life sciences, aiming to accelerate research, improve efficiency, and ultimately bring treatments to patients faster. The platform’s ability to provide actionable intelligence in real-time could significantly impact how companies strategize and respond to emerging trends in the medical field.
For more information about Virtual Science AI’s intelligence solutions, visit www.virtualscienceai.com.
About Virtual Science AI
Virtual Science AI is a global provider of enterprise advisory boards, integrated medical intelligence, social media intelligence, and congress intelligence solutions. The company’s proprietary medical intelligence platform solutions transform complex scientific data into actionable insights, enabling life science teams to drive rapid and effective change at scale.
Headquartered in London, Virtual Science AI operates in Europe, North America, Asia-Pacific, and Latin America. The company offers innovative Software-as-a-Service (SaaS) solutions for the life science and healthcare sectors, working with the majority of the top 20 pharmaceutical companies and numerous biotechnology firms. Virtual Science AI’s proprietary medical intelligence platform solutions transform complex scientific data into actionable insights and enable life science teams to make treatments available to patients worldwide more quickly.
Alison Doughty
Phone: +44 (0)7703 611 620
Email: [email protected]
Logo – https://mma.prnewswire.com/media/2875012/Virtual_Science_AI_Logo.jpg